Skip to main content
Top
Published in: European Journal of Medical Research 1/2017

Open Access 01-12-2017 | Research

Developing a risk prediction model for breast cancer: a Statistical Utility to Determine Affinity of Neoplasm (SUDAN-CA Breast)

Authors: Alaaddin M. Salih, Dafallah M. Alam-Elhuda, Musab M. Alfaki, Adil E. Yousif, Momin M. Nouradyem

Published in: European Journal of Medical Research | Issue 1/2017

Login to get access

Abstract

Background

Breast cancer risk prediction models are widely used in clinical settings. Although most of the well-known models were designed based on data collected from western population, yet they have been utilized for surveillance purposes in many limited-resource countries. Given the genetic variations in risk factors that exist between different races, we therefore aimed to develop and validate a tool for breast cancer risk assessment among Sudanese women.

Methods

Using cross-sectional design, 153 subjects were eligible to participate in our study. Data were collected from the only couple of tertiary centers in Sudan. They underwent multiple logistic regression using purposeful selection method to build the model. Various adjustments were made to determine significant predictors. Overall performance, calibration and discrimination were assessed by R 2, O/E ratio and c-statistic, respectively.

Results

SUDAN predictors of breast cancer were: age, menarche, family history, vegetables and fruits weekly servings, and type of cereals that traditional cuisine is made of. Both Nagelkerke R 2 (0.495) and O/E ratio (0.78) were good. c-statistic expressed the excellent discriminatory power of the model (0.864, p < 0.001, 95% CI 0.81–0.92).

Conclusions

Our findings suggest that SUDAN provides a simple, efficient and well-calibrated tool to predict and classify women’s lifetime risks of developing breast cancer. Input from our model could be deployed to guide utilization of the more advanced screening modalities in resource-limited settings to maximize cost effectiveness. Consequently, this might improve the stage at which the diagnosis is usually made.
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.CrossRefPubMed
3.
go back to reference Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20:1480–90.CrossRefPubMed Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20:1480–90.CrossRefPubMed
4.
go back to reference Bellcross C. Approaches to applying breast cancer risk prediction models in clinical practice. Comm Oncol. 2009;6(8):373–82.CrossRef Bellcross C. Approaches to applying breast cancer risk prediction models in clinical practice. Comm Oncol. 2009;6(8):373–82.CrossRef
5.
go back to reference Nelson HD, Huffman LH, Fu R, et al. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;143(5):362–79.CrossRefPubMed Nelson HD, Huffman LH, Fu R, et al. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;143(5):362–79.CrossRefPubMed
6.
go back to reference Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an ad- junct to mammography. CA Cancer J Clin. 2007;57:75–89.CrossRefPubMed Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an ad- junct to mammography. CA Cancer J Clin. 2007;57:75–89.CrossRefPubMed
7.
go back to reference US Preventive Services Task Force (USPSTF). Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility. Ann Intern Med. 2005;143:355–61.CrossRef US Preventive Services Task Force (USPSTF). Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility. Ann Intern Med. 2005;143:355–61.CrossRef
8.
go back to reference Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 1998;90:1371–88.CrossRefPubMed Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 1998;90:1371–88.CrossRefPubMed
9.
10.
go back to reference Friedenson B. Assessing and managing breast cancer risk: clinical tools for advising patients. Med Gen Med. 2004;6(1):8. Friedenson B. Assessing and managing breast cancer risk: clinical tools for advising patients. Med Gen Med. 2004;6(1):8.
12.
go back to reference Laious M, Boutron-Ruault MC, Fabre A, Clavel-Chapelon F, Romieu I. Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women. Am J Clin Nutr. 2008;87(5):1384–91. Laious M, Boutron-Ruault MC, Fabre A, Clavel-Chapelon F, Romieu I. Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women. Am J Clin Nutr. 2008;87(5):1384–91.
13.
go back to reference Dumitrescu RG, Cotarla I. Understanding breast cancer risk-where do we stand in 2005? J Cell Mol Med. 2005;9(1):208–21.CrossRefPubMed Dumitrescu RG, Cotarla I. Understanding breast cancer risk-where do we stand in 2005? J Cell Mol Med. 2005;9(1):208–21.CrossRefPubMed
14.
go back to reference Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor—defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004;13:1558–68.PubMed Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor—defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004;13:1558–68.PubMed
15.
go back to reference Tsakountakis N, Sanidas E, Stathopoulos E, Kafousi M, Anogiannaki N, Georgoulias V, Tsiftsis DD. Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status. BMC Women’s Health. 2005;5(1):1. doi:10.1186/1472-6874-5-1.CrossRefPubMedPubMedCentral Tsakountakis N, Sanidas E, Stathopoulos E, Kafousi M, Anogiannaki N, Georgoulias V, Tsiftsis DD. Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status. BMC Women’s Health. 2005;5(1):1. doi:10.​1186/​1472-6874-5-1.CrossRefPubMedPubMedCentral
16.
go back to reference Fadl Elmoula RM, Farag Alla HEH. The association of ki67 proliferation marker with estrogen, progesterone and HER2 markers among Sudanese females with breast cancer. J Biomed Pharmaceut Res. 2014;3(6):125–30. Fadl Elmoula RM, Farag Alla HEH. The association of ki67 proliferation marker with estrogen, progesterone and HER2 markers among Sudanese females with breast cancer. J Biomed Pharmaceut Res. 2014;3(6):125–30.
17.
go back to reference Chuthapisith S, Permsapaya W, Warnnissorn M, Akewanlop C, Sirivatanauksorn V, Osoth PP. Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women. Asian Pac J Cancer Prev. 2012;13:459–62.CrossRefPubMed Chuthapisith S, Permsapaya W, Warnnissorn M, Akewanlop C, Sirivatanauksorn V, Osoth PP. Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women. Asian Pac J Cancer Prev. 2012;13:459–62.CrossRefPubMed
18.
go back to reference Telli ML, Chang ET, Kurian AW, Keegan TH, McClure LA, Lichtensztajn D, Ford JM, Gomez SL. Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat. 2011;127:471–8. doi:10.1007/s10549-010-1173-8.CrossRefPubMed Telli ML, Chang ET, Kurian AW, Keegan TH, McClure LA, Lichtensztajn D, Ford JM, Gomez SL. Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat. 2011;127:471–8. doi:10.​1007/​s10549-010-1173-8.CrossRefPubMed
20.
go back to reference Bae YK, Gong G, Kang J, Lee A, Cho EY, Lee JS, Suh KS, Lee DW. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays. Am J Surg Pathol. 2012;36(12):1817–25. doi:10.1097/PAS.0b013e318267b012.CrossRefPubMed Bae YK, Gong G, Kang J, Lee A, Cho EY, Lee JS, Suh KS, Lee DW. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays. Am J Surg Pathol. 2012;36(12):1817–25. doi:10.​1097/​PAS.​0b013e318267b012​.CrossRefPubMed
21.
go back to reference Elnour AM, Elderdery AY, Mills J, Mohammed BA, ElbietAbdelaal D, Mohamed AO, Elhassan KE, Hady A, Wahab A, Cooper A. BRCA 1 & 2 mutations in Sudanese secondary school girls with known breast cancer in their families. Int J Health Sci (Qassim). 2012;6(1):63–71.CrossRef Elnour AM, Elderdery AY, Mills J, Mohammed BA, ElbietAbdelaal D, Mohamed AO, Elhassan KE, Hady A, Wahab A, Cooper A. BRCA 1 & 2 mutations in Sudanese secondary school girls with known breast cancer in their families. Int J Health Sci (Qassim). 2012;6(1):63–71.CrossRef
22.
go back to reference Awadelkarim KD, Aceto G, Veschi S, Elhaj A, Morgano A, Mohamedani AA, Eltayeb EA, Abuidris D, Di Dioacchino M, Battista P, Verginelli F, Cama A, Elwali NE, Mariani-Costantini R. BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors. Breast Cancer Res Treat. 2007;102(2):189–99.CrossRefPubMed Awadelkarim KD, Aceto G, Veschi S, Elhaj A, Morgano A, Mohamedani AA, Eltayeb EA, Abuidris D, Di Dioacchino M, Battista P, Verginelli F, Cama A, Elwali NE, Mariani-Costantini R. BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors. Breast Cancer Res Treat. 2007;102(2):189–99.CrossRefPubMed
23.
go back to reference Biunno L, Aceto G, Awadelkarim KD, Morgano A, Elhaj A, Eltayeb EA, Abuidris DO, Elwali NE, Spinelli C, De Blasio P, Rovida E, Mariani-Costantini R. BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan. Fam Cancer. 2014;13(3):437–44. doi:10.1007/s10689-014-9717-4.CrossRefPubMed Biunno L, Aceto G, Awadelkarim KD, Morgano A, Elhaj A, Eltayeb EA, Abuidris DO, Elwali NE, Spinelli C, De Blasio P, Rovida E, Mariani-Costantini R. BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan. Fam Cancer. 2014;13(3):437–44. doi:10.​1007/​s10689-014-9717-4.CrossRefPubMed
26.
go back to reference Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. Hoboken: John Wiley & Sons, Inc.; 2013. p. 177.CrossRef Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. Hoboken: John Wiley & Sons, Inc.; 2013. p. 177.CrossRef
27.
go back to reference Meads C, Ahmed I, Riley RD. A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat. 2012;132:365–77.CrossRefPubMed Meads C, Ahmed I, Riley RD. A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat. 2012;132:365–77.CrossRefPubMed
30.
go back to reference Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A. An evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet. 2003;40:807–14.CrossRefPubMedPubMedCentral Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A. An evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet. 2003;40:807–14.CrossRefPubMedPubMedCentral
Metadata
Title
Developing a risk prediction model for breast cancer: a Statistical Utility to Determine Affinity of Neoplasm (SUDAN-CA Breast)
Authors
Alaaddin M. Salih
Dafallah M. Alam-Elhuda
Musab M. Alfaki
Adil E. Yousif
Momin M. Nouradyem
Publication date
01-12-2017
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2017
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-017-0277-6

Other articles of this Issue 1/2017

European Journal of Medical Research 1/2017 Go to the issue